Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at three-year follow up

Journal of Heart Valve Disease

Volumn 15, Issue 4, 2006, Pages 540-544

  Yap, Cheng Hon ^a   Skillington, Peter D ^b   Matalanis, George ^c   Davis, Bruce B ^d   Tait, Brian D ^e   Hudson, Fiona ^e   Ireland, Lyn ^f   Nixon, Ian ^a   Yii, Michael ^a,g  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c AUSTIN HEALTH   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e Victorian Transplantation and Immunogenetics Service   (Australia)

^f Donor Tissue Bank of Victoria   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; BLOOD DONOR; CARDIOVASCULAR PARAMETERS; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOPRESERVATION; DONOR; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENETIC PROCEDURES; GRAFT DYSFUNCTION; HEART VALVE REPLACEMENT; HLA TYPING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RECIPIENT; SEROLOGY; SEROPREVALENCE; T LYMPHOCYTE; TISSUE PRESERVATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES; CADAVER; CROSS-SECTIONAL STUDIES; CRYOPRESERVATION; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; ORGAN PRESERVATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33746424825     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lund O, Chandrasekaran V, Grocott-Mason R, et al. Primary aortic valve replacement with allografts over twenty-five years: Valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg 1999;117:77-90
2. O'Brien MF, Harrocks S, Stafford EG, et al. The homograft aortic valve: A 29-year, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 2001;10:334-344
3. Chambers JC, Somerville J, Stone S, Ross DN. Pulmonary autograft procedure for aortic valve disease: Long-term results of the pioneer series. Circulation 1997;96:2206-2214
4. Yap CH, Yii M. Factors influencing late allograft valve failure. Scand Cardiovasc J 2004;38:325-333
5. Dignan R, O'Brien M, Hogan P, et al. Influence of HLA matching and associated factors on aortic valve homograft function. J Heart Valve Dis 2000;9:504-511
6. Dignan R, O'Brien M, Hogan P, et al. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. J Heart Valve Dis 2003;12:382-390
7. Hoekstra FM, Witvliet M, Knoop CY, et al. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg 1998;66:2022-2026
8. Hoekstra F, Witvliet M, Knoop C, et al. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts. J Heart Lung Transplant 1997;16:570-572
9. Baskett RJ, Nanton MA, Warren AE, Ross DB. Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: Implications for therapeutic interventions. J Thorac Cardiovasc Surg 2003;126:232-239
10. QUIKSCREEN®, GTI Incorporated, Product Information. Available at www.gtidiagnostics.com/documentation/hlaelisa /qs3&12g_di_eng_072804.pdf. Accessed 10 July 2005
11. B-SCREEN®, GTI Incorporated, Product Information. Available at www.gtidiagnostics.com/documentation/hlaelisa /bcsg_di_eng_121504.pdf. Accessed 10 July 2005
12. Mittal KK, Mickey MR, Singal DP, Terasaki PI. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 1968;6:913-927
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
14. Kurz B, Steiert I, Heuchert G, Muller CA. New high resolution typing strategy for HLA-A locus alleles based on dye terminator sequencing of haplotypic group-specific PCR-amplicons of exon 2 and exon 3. Tissue Antigens 1999;53:81-96
15. Bechtel JF, Bartels C, Schmidtke C, et al. Anti-HLA class I antibodies and pulmonary homograft function after the Ross procedure. Ann Thorac Surg 2001;71:2003-2007
16. Bechtel JF, Bartels C, Schmidtke C, et al. Does histocompatibility affect homograft valve function after the Ross procedure? Circulation 2001;104(12 Suppl.1):I25-I28
17. Smith JD, Ogino H, Hunt D, Laylor RM, Rose ML, Yacoub MH. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 1995;60(2 Suppl.):S127-S130
18. Hooper DK, Hawkins JA, Fuller TC, Profaizer T, Shaddy RE. Panel-reactive antibodies late after allograft implantation in children. Ann Thorac Surg 2005;79:641-644
19. Lucas DP, Paparounis ML, Myers L, Hart JM, Zachary AA. Detection of HLA class I-specific antibodies by the Quikscreen enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 1997;4:252-257
20. Worthington JE, Robson AJ, Sheldon S, Langton A, Martin S. A comparison of enzyme-linked immunosorbent assays and flow cytometry techniques for the detection of HLA specific antibodies. Hum Immunol 2001;62:1178-1184
21. Hawkins JA, Breinholt JP, Lambert LM, et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg 2000;119:324-330
22. Novotny VM, van Doorn R, Witvliet MD, Claas FH, Brand A. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: A prospective study. Blood 1995;85:1736-1741
23. Hawkins JA, Hillman ND, Lambert LM, et al. Immunogenicity of decellularised cryopreserved allografts in pediatric cardiac surgery: Comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg 2003;126:247-252
24. Bechtel JF, Muller-Steinhardt M, Schmidtke C, Brunswik A, Stierle U, Sievers HH. Evaluation of the decellularized pulmonary valve homograft (SynerGraft). J Heart Valve Dis 2003;12:734-739